GAZI UNIVERSITY INFORMATION PACKAGE - 2019 ACADEMIC YEAR

COURSE DESCRIPTION
DRUG SCREENING TESTS I/FRL-1050
Course Title: DRUG SCREENING TESTS I
Credits 3 ECTS 6
Course Semester 1 Type of The Course Elective
COURSE INFORMATION
 -- (CATALOG CONTENT)
 -- (TEXTBOOK)
 -- (SUPPLEMENTARY TEXTBOOK)
 -- (PREREQUISITES AND CO-REQUISITES)
 -- LANGUAGE OF INSTRUCTION
  Turkish
 -- COURSE OBJECTIVES
 -- COURSE LEARNING OUTCOMES
1. To comprehend the features and the timing of the primary screening studies without using live animals
2. To comprehend secondary screening studies are done to evaluate the threshold effect and dose-response relationship
3. To aware of follow-up studies are done later stage in the process of drug development
4. To understand of the approaches used for the purpose of new drug development
5. To understand of the concepts of agonist, parsiyel agonist and antagonist
6. To classify ot thedDrug screening tests

 -- MODE OF DELIVERY
  The mode of delivery of this course is Face to face
 --WEEKLY SCHEDULE
1. Week  Stages of drug development
2. Week  Stages of drug development
3. Week  The different approaches used in drug discovery
4. Week  The different approaches used in drug discovery
5. Week  Number and type of initial screening tests
6. Week  Number and type of initial screening tests
7. Week  The identification of pharmacological profile of a drug
8. Week  The identification of pharmacological profile of a drug
9. Week  Primary and secondary screening and follow-up studies
10. Week  Primary and secondary screening and follow-up studies
11. Week  Screening tests on receptor binding affinity
12. Week  Screening tests on receptor binding affinity
13. Week  Screening tests on receptor binding affinity
14. Week  To determine if a drug is agonist, partial agonist or antagonist
15. Week  To determine if a drug is agonist, partial agonist or antagonist
16. Week  EXAM
 -- TEACHING and LEARNING METHODS
 -- ASSESSMENT CRITERIA
 
Quantity
Total Weighting (%)
 Midterm Exams
1
20
 Assignment
1
10
 Application
1
10
 Projects
0
0
 Practice
0
0
 Quiz
1
0
 Percent of In-term Studies  
40
 Percentage of Final Exam to Total Score  
60
 -- WORKLOAD
 Activity  Total Number of Weeks  Duration (weekly hour)  Total Period Work Load
 Weekly Theoretical Course Hours
12
3
36
 Weekly Tutorial Hours
0
 Reading Tasks
14
3
42
 Searching in Internet and Library
14
3
42
 Material Design and Implementation
2
3
6
 Report Preparing
0
 Preparing a Presentation
0
 Presentation
0
 Midterm Exam and Preperation for Midterm Exam
1
7
7
 Final Exam and Preperation for Final Exam
1
14
14
 Other (should be emphasized)
0
 TOTAL WORKLOAD: 
147
 TOTAL WORKLOAD / 25: 
5.88
 Course Credit (ECTS): 
6
 -- COURSE'S CONTRIBUTION TO PROGRAM
NO
 PROGRAM LEARNING OUTCOMES
1
2
3
4
5
1Can obtain current pharmacological knowledge in a systematically approach.X
2Contribute to science by expanding the boundaries of knowledge in the field of pharmacology.X
3Define the scientific research methods of the discipline of pharmacology. Plan, conduct and analyze a scientific research and write and publish the data.X
4Can access scientific data and interpret data critically.X
5Prepare a scientific presentation and present it properly.X
6Have the adequate knowledge and skills of research techniques to be able to take part in experiments conducted with laboratory animals.X
7Adopts the ethical and other responsibilities imposed by the discipline of pharmacology.X
8Should be able to read, analyze and evaluate the publications in the field of pharmacology published in a foreign language at international levels.X
9Accepts the value of evidence-based scientific thinking and critical thinking approach in the field of pharmacology and its applications, and attaches importance to lifelong learning.X
10Be able to evaluate a scientific research project within the discipline of pharmacology from an ethical.X
 -- NAME OF LECTURER(S)
   (Assoc.Prof. Sevil ÖZGER İLHAN)
 -- WEB SITE(S) OF LECTURER(S)
   (http://www.websitem.gazi.edu.tr/site/soilhan)
 -- EMAIL(S) OF LECTURER(S)
   (soilhan@gazi.edu.tr)